Ledger.Open graph →
SEC Form D · filed March 6, 2017

Sun BioPharma, Inc

Offering
$5.0M
Sold
$1.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WACONIA, MN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Suzanne T. Gagnon · Waconia, MNDirectorPaul W. Schaffer · Waconia, MNDirectorDavid B. Kaysen · DALLAS, TXExec · DirectorD. R. Schemel · Spicer, MNDirectorScott R. Kellen · Waconia, MNExecJeffrey S. Mathiesen · Waconia, MNDirectorMichael T. Cullen · Waconia, MNExec · DirectorJ. R. Paulson, Jr · Waconia, MNDirectorDalvir S. Gill · Waconia, MNDirectorSuzanne T. Gagnon · Waconia, MNDirectorPaul W. Schaffer · Waconia, MNDirectorDavid B. Kaysen · DALLAS, TXExec · DirectorD. R. Schemel · Waconia, MNDirectorScott R. Kellen · Waconia, MNExecJeffrey S. Mathiesen · Waconia, MNDirectorMichael T. Cullen · Waconia, MNExec · DirectorJ. R. Paulson, Jr · Waconia, MNDirectorDalvir S. Gill · Waconia, MNDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗